Otsuka America Pharmaceutical, Inc.
Registered Principal Details
Business Or Interest:
Pharmaceutical manufacturer
Lobbying Interests:
All matters related to healthcare and pharmaceuticals.
CEO Name:
Kabir Nath
West Area Director
Pharmaceutical manufacturer
Lobbying Interests:
All matters related to healthcare and pharmaceuticals.
CEO Name:
Kabir Nath
West Area Director
Contact
KS
Kelli Strother
2440 Research Boulevard
Rockville, MD 20850
(303) 524-2113
Kelli.Strother@otsuka-us.com
http://www.otsuka-us.com
2440 Research Boulevard
Rockville, MD 20850
(303) 524-2113
Kelli.Strother@otsuka-us.com
http://www.otsuka-us.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 184
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
For
Notification Date3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 290
Relating to: reimbursement of pharmacist services under the Medical Assistance program. (FE)
Bill Text and History
4/27/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: reimbursement of pharmacist services under the Medical Assistance program. (FE)
Bill Text and History
For
Notification Date4/27/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 744
Relating to: rare disease advisory council. (FE)
Bill Text and History
12/14/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: rare disease advisory council. (FE)
Bill Text and History
For
Notification Date12/14/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Joint Resolution 29
Relating to: proclaiming March 2021 to be Kidney Month in Wisconsin.
Bill Text and History
4/29/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: proclaiming March 2021 to be Kidney Month in Wisconsin.
Bill Text and History
For
Notification Date4/29/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Resolution 24
Relating to: observing February 28, 2022, as Rare Disease Day in Wisconsin.
Bill Text and History
1/31/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: observing February 28, 2022, as Rare Disease Day in Wisconsin.
Bill Text and History
For
Notification Date1/31/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 215
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
3/22/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
For
Notification Date3/22/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 255
Relating to: reimbursement of pharmacist services under the Medical Assistance program. (FE)
Bill Text and History
2021 Wisconsin Act 98
4/13/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: reimbursement of pharmacist services under the Medical Assistance program. (FE)
Bill Text and History
2021 Wisconsin Act 98
For
Notification Date4/13/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 689
Relating to: rare disease advisory council. (FE)
Bill Text and History
11/18/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: rare disease advisory council. (FE)
Bill Text and History
For
Notification Date11/18/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
2023-25 Biennial Budget Bill
2023-25 Biennial Budget Bill
Action Intended To Affect
Both Legislative matter and rule
Notification Date
10/4/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative matter and rule
Notification Date
10/4/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Rare Diseases
Rare Diseases
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/13/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
3/13/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
the application of prescription drug payments for health coverage
the application of prescription drug payments for health coverage
Action Intended To Affect
Legislative matter
Notification Date
3/13/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
3/13/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Mental Health Protections and Parity
Mental Health Protections and Parity
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/13/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
3/13/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2021 January - June $9,363.21 |
2021 July - December $28,257.92 |
2022 January - June $25,755.11 |
2022 July - December $24,542.83 |
Total $87,919.07 |
| Total Hours Communicating | 2021 January - June 1.20 |
2021 July - December 21.05 |
2022 January - June 7.55 |
2022 July - December 7.25 |
Total 37.05 |
| Total Hours Other | 2021 January - June 42.60 |
2021 July - December 72.10 |
2022 January - June 68.75 |
2022 July - December 50.15 |
Total 233.60 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: proclaiming March 2021 to be Kidney Month in Wisconsin.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 5% |
2021 July - December |
2022 January - June |
2022 July - December |
Total < 1% |
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 30% |
2021 July - December 25% |
2022 January - June 30% |
2022 July - December 50% |
Total 33% |
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 30% |
2021 July - December 25% |
2022 January - June 30% |
2022 July - December 50% |
Total 33% |
Relating to: rare disease advisory council. (FE)
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December 15% |
2022 January - June 15% |
2022 July - December |
Total 9% |
Relating to: rare disease advisory council. (FE)
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December 15% |
2022 January - June 15% |
2022 July - December |
Total 9% |
Relating to: observing February 28, 2022, as Rare Disease Day in Wisconsin.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December |
2022 January - June 10% |
2022 July - December |
Total 3% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 5% |
2021 July - December |
2022 January - June |
2022 July - December |
Total < 1% |
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 10% |
2021 July - December 20% |
2022 January - June |
2022 July - December |
Total 9% |
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 20% |
2021 July - December |
2022 January - June |
2022 July - December |
Total 3% |
Minor Efforts
No minor efforts found.
Other Matters
No other matters found.